Cargando…

Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design

BACKGROUND: Dexamethasone, a highly effective drug in treating pediatric acute lymphoblastic leukemia (ALL), can induce serious neurobehavioral side effects. These side effects are experienced by patients and parents as detrimental with respect to health related quality of life (HRQoL). Based on pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Hulst, A. M., Verwaaijen, E. J., Fiocco, M. F., Pluijm, S. M. F., Grootenhuis, M. A., Pieters, R., van den Akker, E. L. T., van den Heuvel-Eibrink, M. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474814/ https://www.ncbi.nlm.nih.gov/pubmed/34579671 http://dx.doi.org/10.1186/s12887-021-02896-6

Ejemplares similares

Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?
por: van Hulst, Annelienke M., et al.
Publicado: (2023)

Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study
por: Verwaaijen, Emma Jacobine, et al.
Publicado: (2022)

The utility of a portable muscle ultrasound in the assessment of muscle alterations in children with acute lymphoblastic leukaemia
por: Verwaaijen, Emma J., et al.
Publicado: (2023)

Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia
por: Verwaaijen, Emma J., et al.
Publicado: (2023)

The DEXA-CORT trial: study protocol of a randomised placebo-controlled trial of hydrocortisone in patients with brain tumour on the prevention of neuropsychiatric adverse effects caused by perioperative dexamethasone
por: Koning, Anne-Sophie C A M, et al.
Publicado: (2021)

Risk factors for steroid‐induced adverse psychological reactions and sleep problems in pediatric acute lymphoblastic leukemia: A systematic review
por: van Hulst, Annelienke M., et al.
Publicado: (2021)

Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone
por: Warris, Lidewij T., et al.
Publicado: (2016)

Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols
por: van Atteveld, Jenneke E., et al.
Publicado: (2021)

Dexa Body Composition Assessment in 10-11 Year Healthy Children
por: Verduin, W. M., et al.
Publicado: (2016)

Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors
por: Verwaaijen, Emma J, et al.
Publicado: (2021)

A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia
por: Oosterom, N., et al.
Publicado: (2018)

DEXA Conference
Publicado: (1993)

Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022)

The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia
por: Oosterom, N., et al.
Publicado: (2020)

Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors
por: van Waas, Marjolein, et al.
Publicado: (2012)

Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia
por: Oosterom, Natanja, et al.
Publicado: (2019)

Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia
por: van Atteveld, Jenneke E, et al.
Publicado: (2021)

Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency
por: Schröder, Mariska A M, et al.
Publicado: (2021)

Fatigue among children with a chronic disease: a cross-sectional study
por: Nap-van der Vlist, Merel M, et al.
Publicado: (2021)

Can biomarkers be used to improve diagnosis and prediction of metabolic syndrome in childhood cancer survivors? A systematic review
por: Pluimakers, Vincent G., et al.
Publicado: (2021)

Fasting Intervention for Children With Unilateral Renal Tumors to Reduce Toxicity
por: Oudmaijer, Christiaan A. J., et al.
Publicado: (2022)

Parents' experiences with large‐scale sequencing for genetic predisposition in pediatric renal cancer: A qualitative study
por: Bon, Sebastian B. B., et al.
Publicado: (2022)

Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia
por: Dauber, Andrew, et al.
Publicado: (2010)

MON-096 Body Composition in Patients with Craniopharyngioma: Is DXA-Scanning Necessary for Evaluating the Metabolic Syndrome?
por: van Santen, Selveta, et al.
Publicado: (2019)

Ultralow-dose Dexamethasone to Preserve Endogenous Cortisol Stress Response in Nonclassical Congenital Adrenal Hyperplasia: A New Promising Treatment
por: van der Kaay, Danielle, et al.
Publicado: (2014)

Nutritional Preconditioning in Cancer Treatment in Relation to DNA Damage and Aging
por: van den Boogaard, Winnie M.C., et al.
Publicado: (2021)

Mild intracellular acidification by dexamethasone attenuates mitochondrial dysfunction in a human inflammatory proximal tubule epithelial cell model
por: Schirris, T. J. J., et al.
Publicado: (2017)

Obesity Is Underestimated Using Body Mass Index and Waist-Hip Ratio in Long-Term Adult Survivors of Childhood Cancer
por: Blijdorp, Karin, et al.
Publicado: (2012)

Higher hydrocortisone dose increases bilirubin in hypopituitary patients‐ results from an RCT
por: Werumeus Buning, Jorien, et al.
Publicado: (2016)

Combined intravitreal dexamethasone and bevacizumab injection for the treatment of persistent diabetic macular edema (DexaBe study): a phase I clinical study
por: Veiga Reis, Francyne, et al.
Publicado: (2023)

Two cases of left-sided and concomitant right-sided endocarditis: potential pathways of spreading
por: van der Zee, P. M., et al.
Publicado: (2011)

A Study on Prevalence and Determinants of Ototoxicity During Treatment of Childhood Cancer (SOUND): Protocol for a Prospective Study
por: Diepstraten, Franciscus A, et al.
Publicado: (2022)

Identifying the critically ill paediatric oncology patient: a study protocol for a prospective observational cohort study for validation of a modified Bedside Paediatric Early Warning System score in hospitalised paediatric oncology patients
por: Soeteman, Marijn, et al.
Publicado: (2021)

Assessing fatigue in childhood cancer survivors: Psychometric properties of the Checklist Individual Strength and the Short Fatigue Questionnaire––a DCCSS LATER study
por: Penson, Adriaan, et al.
Publicado: (2021)

TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration
por: Gooskens, Saskia L., et al.
Publicado: (2017)

Correction: Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia
por: Driehuis, E., et al.
Publicado: (2020)

Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia
por: Driehuis, E., et al.
Publicado: (2020)

Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia
por: Oosterom, Natanja, et al.
Publicado: (2018)

Reproducibility and utility of an overnight 0.25 mg dexamethasone suppression test as a marker for glucocorticoid sensitivity in children with asthma
por: Willemsen, R. H., et al.
Publicado: (2015)

Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisited
por: Obulkasim, Askar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b20uljjro2eu1nlfo8eda80f93